The term sheet that lets you keep shares, then stops you buying machines

Most founders negotiate Series A like it is a debate about price. In manufacturing, it is an argument about permissions and escape hatches.

Sunfire’s March 2024 announcement reads like a small country’s budget.

Sunfire, the German electrolyser manufacturer, said it had secured €215m in Series E equity, plus up to €100m in a European Investment Bank term loan, and referenced €200m of previously approved undrawn grant funding.

It is a triumphant headline. It also points at a quieter truth.

In industrial businesses, money is not just raised. It is released.

Because the most dangerous moment is not the press release.

It is the moment you try to spend.

Imagine you are a Western European manufacturing founder. You have just closed Series A. The cash hits the bank. Your supplier needs a deposit to start a long lead-time machine. Your customer’s qualification window is pencilled in. Your schedule is tight.

Then you discover a sentence in the term sheet you treated as “standard”. It says capex over a threshold needs investor director approval.

You are not out of money.

You are blocked from using it.

Sunfire, the German electrolyser manufacturer, illustrates how industrial scale-ups plan around capex headroom using multiple funding sources. Photo: TRx340 / Wikimedia Commons, CC BY-SA 4.0.

Here is the simple question this raises.

What matters more: the price you brag about, or the clauses that decide whether you are allowed to execute the plan?

The easy myth: “Series A is mostly about valuation”

Most first-time founders walk into Series A thinking the negotiation is a tug of war over valuation and dilution.

They assume the rest is boilerplate. Market terms. Template stuff.

They assume those clauses only bite in edge cases.

The twist: industrial businesses live inside the “edge case”

In capital-light software, you can often change your burn in a week.

In manufacturing, you cannot.

You have equipment lead times. You have customer qualification and certification. You have lumpy capex, meaning spend lands in big, awkward chunks.

So you spend first, then wait.

And while you wait, the term sheet becomes your operating system.

A budget approval right is not a governance detail. It is a stop button.

A capex consent right is not just investor protection. It is a gate on your factory plan.

Here is the twist most people miss.

Series A has two prices.

The first is valuation.

The second is what happens to you if timing goes wrong.

HSBC Innovation Banking’s VC Term Sheet Guide 2024 says liquidation preference is “the next most important economic term” after valuation. Liquidation preference is the rule that decides who gets paid first in an exit.

That line is not legal nit-picking.

It is a warning label.

The hidden “permission system” inside a founder-friendly board

Founders often relax when they see a board that looks balanced.

Two founders. Two investors. One independent.

It feels like democracy.

Here is the twist.

You can have that board and still lose day-to-day control.

Y Combinator’s Series A template flags the trap: even with a founder-friendly board, founders can lose control through separate investor-director approval requirements for operational decisions like annual budgets, executive hiring and firing, and pivots.

Translated: the board can look friendly, but the fine print can add a password prompt to your plan.

So what happens when that password prompt appears at the worst possible time?

The case where “consent” allegedly became shutdown risk

On 20 July 2026, the Harvard Law School Forum on Corporate Governance posted an analysis titled “Chancery Finds Potential Liability for Blocking Company Financings Despite Contractual Veto Rights”. It discusses a Delaware Court of Chancery decision.

The post describes allegations that a director’s approval was required for financings, that approval was delayed or refused, and that the company allegedly could not secure funding and had to shut down.

That is the operational point founders should sit with.

Not the legal drama. The clock.

In long-cycle businesses, bridge timing is everything. A consent right that slows a financing by weeks can break a certification schedule. It can miss a supplier deposit window. It can spook a customer who wants delivery dates.

This is why the common founder belief is so dangerous.

“A veto is just protection. It won’t be used to stop survival financing.”

Maybe it will not be used to stop it.

It only has to delay it.

Now zoom out.

A blocked financing is one way a term sheet throttles you.

The other way is quieter, and it shows up when you are tired.

The recap moment: when the term sheet becomes the steering wheel

Founders picture the happy path.

Series A. Series B. Then an exit where everyone wins.

Industrial businesses have a different rhythm.

They hit “known unknowns”. Certification delays. Yield issues. Working capital spikes.

So the term sheet must be read as a plan for the stressed path.

In a Delaware case summarised via vLex, New Enterprise Associates 14, L.P. v. Rich (Del. Ch. 2023), preferred holders had liquidation preference equal to invested capital and board appointment rights, and a recap was presented as the “only option”.

You do not need to know every legal detail to see the shape.

When the same people have both board influence and senior economic rights, the menu of options can narrow in distress.

And when the menu narrows, the “best outcome” starts looking suspiciously like the outcome that best fits the existing paperwork.

That is not a morality play.

It is mechanics.

A loud example of a quiet truth: Byju’s and the tyranny of who can fund

Byju’s is an Indian education company, not a manufacturer.

But its February 2024 funding episode is a clean example of what happens when price stops being the story.

TechCrunch reported that Byju’s said its $200m rights issue, which cut valuation by about 99%, was fully subscribed.

Most readers fixate on the number.

The deeper lesson is the power shift.

In stress, the headline valuation is already gone.

The real fight becomes: who puts in cash now, on what terms, and who gets diluted if they cannot.

In an industrial start-up, swap “rights issue” for “inside-led bridge” and the logic is the same.

When you need more money, the people who can fund get to rewrite the rules.

Byju’s rights issue shows that in distress, funding mechanics and participation can matter more than valuation optics. Photo: cherian_in / Wikimedia Commons, CC BY 2.0.

Now come back to Western Europe and manufacturing.

The point is not that every company will face a blow-up.

It is that industrial timelines make these moments predictable.

You will spend before you earn.

So the clauses that govern spend and survival matter more than the headline price.

Sunfire’s hidden lesson: capex headroom is a strategy, not a feeling

Sunfire’s March 2024 announcement is not a Series A template.

It is a reminder that industrial growth is constrained by capex scale.

Sunfire said its package included €215m of equity, up to €100m of European Investment Bank term loan, and referenced €200m of previously approved undrawn grant funding.

One important fix to how we should read that headline.

The “more than €500m” framing is Sunfire’s own statement, not an independently corroborated total.

But you do not need the slogan to learn the lesson.

The fact pattern already tells you the core point: the company is thinking in a stack of instruments, built to preserve spending room through a long build cycle.

That is what many Series A negotiations accidentally destroy.

They win price, then lose permission.

Sunfire referenced up to €100m of European Investment Bank term loan as part of its funding mix. Photo: Caroline Martin / Wikimedia Commons, CC BY-SA 3.0 igo.

The world tour: the same fight, different arenas

In the United States, the Delaware Court of Chancery discussion shows how financing consent can become a timing weapon, according to the Harvard Law School Forum post.

In the same Delaware ecosystem, New Enterprise Associates 14, L.P. v. Rich shows how control rights plus preference rights can shape recap outcomes in stress, as summarised by vLex.

In India, Byju’s shows how quickly the conversation shifts from valuation optics to participation mechanics, according to TechCrunch.

In Norway, Atlantic Sapphire ASA, the publicly listed aquaculture company, published Euronext company news on 23 May 2026 describing a restructuring and long-term financing solution, including an equity issuance at a low price.

Different places. Same pattern.

When cash timing is your enemy, structure dictates strategy.

Atlantic Sapphire’s restructuring shows how capital structure resets can become the survival lever in capital-intensive models. Photo: Raul Ling / Pexels, Pexels licence (free commercial use).

The pattern you can retell at dinner

Think of a term sheet as two stacks.

The control stack decides what you are allowed to do.

The liquidity stack decides what happens if the plan breaks.

In industrial businesses, those stacks reach right down to the factory floor.

They decide whether you can place the deposit. Hire the person who fixes yield. Fund the bridge that gets you through certification.

That is why the “price-first” myth is so costly.

Founders optimise for dilution today, then trade away autonomy tomorrow.

When the opposite is true

Not every company is constrained this way.

If your business has low capex, short sales cycles, and fast iteration, budget and capex consent rights may rarely constrain you.

And if you have credible, fast alternatives for funding, a financing veto is less threatening because you can walk.

This article does not prove valuation never matters.

It proves that, in long-cycle industrial models, valuation is often not the binding constraint.

The binding constraint is whether your operating plan fits inside the permissions you signed.

For founders: negotiate for industrial reality, not the template

Here is how to make this practical.

1) Start with the clock, not the cap table

Write the next 12 months of time-sensitive items.

Equipment deposits. Supplier lead times. Customer qualification. Certification windows.

Then ask a blunt question: “What breaks if we slip eight weeks?”

2) Treat budget and capex consent like product requirements

Do not argue ideology about “control”.

Argue execution.

If investors want consent rights, push for pre-approved spend bands and clear thresholds. Build an explicit capex envelope that matches your milestone physics.

3) If you concede a veto, buy speed

If a director-level approval is required for financings or budgets, design it so it cannot become a slow internal process.

The Delaware Court of Chancery discussion is a reminder of what happens when “consent” meets a ticking runway.

4) Price the second price

Read liquidation preference and down-round mechanics the way you read valuation.

Ask: “If we need another round at a lower price, what happens to control and ownership?”

Mechanically. Not emotionally.

Byju’s is a reminder that in stress, mechanics are the whole story.

5) Build optionality early

Optionality is your best defence against permission squeeze.

If you want more on how funders assess preparedness before they commit, see Capital moves on trust: what funders expect before they look at anything.

For investors: these clauses are rational, but never neutral

Investors are not villains for wanting control and downside protection.

They are managing two fears.

First, that money will be spent in irreversible ways.

Second, that in distress, earlier investors will subsidise later ones.

A budget or capex consent right slows irreversible decisions.

Liquidation preference defines who gets paid first.

Pay-to-play is a rule that punishes investors who do not participate in later rounds.

The mistake is pretending these terms are harmless.

Experienced industrial investors check fit.

Does governance match the certification and sales cycle? Does the company have enough spending room to hit milestones without constant permission requests?

They also test financing speed. Because if consent can slow survival funding, timing becomes existential.

If you want a parallel from another world where timing and controls dominate outcomes, read UK Development Bridge Finance 2025-2026: Exit Risk and Monitoring.

What GI Network would do before you sign

GI Network would treat your Series A term sheet like an operating plan under stress.

We would map your capex and certification timeline against the control stack in the draft terms, identify where budget and capex consents create execution choke points, and structure counter-proposals that preserve investor protections while keeping pre-approved spend bands and financing speed. Then we would pressure-test the liquidity stack, including liquidation preference and down-round mechanics, against realistic delay scenarios, and rehearse investor committee objections so the documents match what industrial investors can underwrite.

GI Network’s view: In industrial Series A, the most dangerous sentence is not the valuation. It is the one that says you need approval to keep the plan moving.

If you are still building the diligence package that makes these negotiations easier, Pre-Seed Diligence: What Investors Check Pre-Revenue (2025) is a useful baseline even for later rounds.

The takeaway tool: the “Two Stacks and a Clock” check

Before you sign, run this test.

Step 1: Write your clock

List your next three time-sensitive milestones.

In industrial businesses, they are often equipment lead time, certification gates, and customer contract timing.

Step 2: Write the two stacks

Control stack: who must approve budgets, capex, financings, key hires.

Liquidity stack: liquidation preference, and any rules that change outcomes in a down-round.

Step 3: Ask one brutal question

If we slip one milestone by 60 days, do these clauses help us recover, or do they trap us?

If they trap you, the price is not the problem.

The permissions are.